mesothelioma Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery The French bioinformatics firm will analyze molecular and other multimodal data in search of new cancer therapeutics. Cellular Analytics Eyes Early Mesothelioma Detection Using Liquid Biopsy Tech Premium The firm's assay, dubbed MesoFind, uses an immunomagnetic capture method to identify surface antigens on mesothelioma pleural cells in a patient's blood sample. CAR T Cell Therapies Targeting HER2, Mesothelin Show Activity in Solid Tumors Premium In the hunt for an antigen in solid tumors that CAR T cells can target, researchers demonstrate the safety and efficacy profile of two such agents in early studies. MSI Tumor Analysis Implicates Lynch Syndrome in Several New Cancer Types In a pan-cancer analysis, Lynch syndrome genes were mutated more often than anticipated in tumors with high or intermediate levels of microsatellite instability. New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma. Feb 29, 2016 Study IDs Recurrent Mesothelioma Tumor Alterations Dec 18, 2014 Castle's Eye Cancer Test Widely Adopted as Firm Anticipates Growth Beyond Niche Cancer Market Premium Sep 4, 2014 ADRI Begins Phase I Trial of microRNA Mimic for Mesothelioma Premium Aug 13, 2014 Cancer MDx Firm Castle Biosciences Raises $11.8M Oct 5, 2012 Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma Premium Sep 12, 2012 Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test May 10, 2012 Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma Premium Jun 16, 2011 Rosetta Signs Marketing Deal for Mesothelioma Test with Tort Claims Administration Firm Premium Jun 14, 2011 Rosetta Genomics, Pace Ally on Mesothelioma Test Marketing, Services Apr 8, 2011 NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma Premium Dec 30, 2010 CDC Plans $5M for Mesothelioma Biobank Oct 15, 2010 Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma Premium Feb 18, 2010 Q&A: NYU Langone Medical Center's Harvey Pass on miR-29c* and Mesothelioma Prognosis Premium Apr 30, 2009 Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008 Premium Apr 30, 2009 Rosetta, Prometheus Close Deal for miRNA Dx Market Rights Premium Apr 16, 2009 Rosetta Grants Prometheus Rights to Sell Suite of microRNA Diagnostics in US Premium Mar 5, 2009 CombiMatrix Aims to Launch miRNA-Based Cancer Screen by Mid-2010 Premium Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.